BioSpace News Archive

Press Releases

Spiro Medical Secures $67 Million Series A Financing to Develop a Neuromodulation System for Asthma

January 8, 2026
·
2 min read
Press Releases

EOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147

January 8, 2026
·
7 min read
Press Releases

FibroBiologics CEO Issues Letter to Shareholders

January 8, 2026
·
8 min read
Press Releases

Aspen Neuroscience Appoints Chief Commercial Officer Lisa Johnson-Pratt, M.D. and Welcomes Revati Shreeniwas, M.D., FCCP as Chief Medical Officer to Accelerate Late‑Stage Development and Commercial Readiness

January 8, 2026
·
4 min read
Press Releases

The American Diabetes Association Welcomes 2026 Principal Officers and Members to the National Board of Directors

January 8, 2026
·
8 min read
Press Releases

Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargardt Disease

January 8, 2026
·
3 min read
Press Releases

Ventus Therapeutics Announces Nomination of VENT-04, a First-in-Class, Oral, Small-Molecule Caspase-4/5 Inhibitor, as a Development Candidate

January 8, 2026
·
3 min read
Press Releases

ILUMYA® (tildrakizumab) Pen (Auto-Injector) Now Available for Canadians Living with Moderate-to-Severe Plaque Psoriasis

January 8, 2026
·
5 min read
Press Releases

Corsera Health Announces $80 Million Series A Financing and Reaches Key Clinical Milestone

January 8, 2026
·
5 min read
Press Releases

Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

January 8, 2026
·
9 min read